Old Web
English
Sign In
Acemap
>
Paper
>
Optimization of ML321: a D 2 dopamine receptor‐selective antagonist for the treatment of neuropsychiatric disorders
Optimization of ML321: a D 2 dopamine receptor‐selective antagonist for the treatment of neuropsychiatric disorders
2021
Julia Rocereta
R. Free
Andres Dulcey Garcia
Noel Southall
Lei Shi
J. Lane
William C. Wetsel
Juan J. Marugan
David R. Sibley
Keywords:
Pharmacology
Chemistry
Dopamine receptor
selective antagonist
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]